E Lissen

Author PubWeight™ 50.33‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997 4.08
2 [Prevalence of antibodies against hepatitis C virus in a sample of homosexual males]. Med Clin (Barc) 1993 1.94
3 Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain. J Clin Microbiol 1998 1.17
4 Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries. AIDS 1998 1.14
5 The role of serology in the diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type-1. Am J Trop Med Hyg 1998 1.13
6 Predictive value of IgM antibodies to hepatitis C virus in patients with chronic hepatitis C undergoing interferon-alpha therapy. Analysis by two different methods. J Viral Hepat 1994 1.08
7 High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients. Am J Trop Med Hyg 1999 1.03
8 CD4+ and CD8+ T lymphocyte regeneration after anti-retroviral therapy in HIV-1-infected children and adult patients. Clin Exp Immunol 2000 0.99
9 Frequency of subclinical visceral leishmaniasis in HIV-1-infected patients in Spain. Eur J Clin Microbiol Infect Dis 1996 0.98
10 Unexpected high prevalence of hepatitis C virus genotype 4 in Southern Spain. J Hepatol 1997 0.97
11 Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C. Eur J Clin Microbiol Infect Dis 1995 0.96
12 Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity. J Hepatol 1993 0.93
13 Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus coinfection: results of a randomized clinical study. Antimicrob Agents Chemother 2005 0.93
14 Thymic volume is associated independently with the magnitude of short- and long-term repopulation of CD4+ T cells in HIV-infected adults after highly active antiretroviral therapy (HAART). Clin Exp Immunol 2004 0.93
15 Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations. J Viral Hepat 2004 0.90
16 Usefulness of route of transmission, absolute CD8+ T-cell counts, and levels of serum tumor necrosis factor alpha as predictors of survival of HIV-1-infected patients with very low CD4 + T-cell counts. Eur J Clin Microbiol Infect Dis 2001 0.89
17 Is hepatitis G virus transmitted sexually? JAMA 1997 0.89
18 Influence of hepatitis C virus infection on the mortality of antiretroviral-treated patients with HIV disease. Eur J Clin Microbiol Infect Dis 1998 0.89
19 Low sensitivity of peripheral blood smear for diagnosis of subclinical visceral leishmaniasis in human immunodeficiency virus type 1-infected patients. J Clin Microbiol 1998 0.89
20 Emergence and clinical relevance of mutations associated with zidovudine resistance in asymptomatic HIV-1 infected patients. Eur J Clin Microbiol Infect Dis 1995 0.88
21 Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients. Lancet 1988 0.87
22 Changes in thymus volume in adult HIV-infected patients under HAART: correlation with the T-cell repopulation. Clin Exp Immunol 2002 0.87
23 Specificity of a commercial indirect immunofluorescence technique in the diagnosis of visceral leishmaniasis in patients infected with HIV-1. Trans R Soc Trop Med Hyg 1996 0.86
24 Increase in the frequency of mutation at codon 215 associated with zidovudine resistance in HIV-1-infected antiviral-naive patients from 1989 to 1996. AIDS 1997 0.86
25 Reduction of immune system activation in HIV-1-infected patients undergoing highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis 1999 0.85
26 Influence of highly active antiretroviral therapy on the outcome of subclinical visceral leishmaniasis in human immunodeficiency virus-infected patients. Clin Infect Dis 2001 0.85
27 Evidence of increased risk for leishmania infantum infection among HIV-seronegative intravenous drug users from southern Spain. Eur J Clin Microbiol Infect Dis 2001 0.84
28 Significance of indeterminate reactivity to human T-cell lymphotropic virus in western blot analysis of individuals at risk. Eur J Clin Microbiol Infect Dis 1997 0.83
29 Tumor necrosis factor beta and soluble APO-1/Fas independently predict progression to AIDS in HIV-seropositive patients. AIDS Res Hum Retroviruses 1998 0.82
30 AIDS in haemophilia patients in Spain. Lancet 1983 0.81
31 Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection. AIDS 1997 0.81
32 HIV-1 plasma viremia not increased in patients receiving highly active antiretroviral therapy after influenza vaccination. Eur J Clin Microbiol Infect Dis 2001 0.81
33 Prevalence of infection by human T-cell leukemia virus types I and II in southern Spain. Eur J Clin Microbiol Infect Dis 1995 0.80
34 False-positive results of leishmanin skin test due to phenol-containing diluent. Trans R Soc Trop Med Hyg 2001 0.80
35 [P. falciparum and P. malariae malaria complicated by pulmonary edema with disseminated intravascular coagulation]. Presse Med 1983 0.80
36 Melatonin biosynthesis in the thymus of humans and rats. Cell Mol Life Sci 2007 0.79
37 Rate of development of mutation at codon 215 of HIV-1 reverse transcriptase and its predictive factors at the time of initiation of zidovudine therapy. Eur J Clin Invest 1996 0.79
38 Rapid progression to liver cirrhosis of toxic hepatitis due to ebrotidine. J Hepatol 1999 0.79
39 [Impact of medical approach on the presentation form of AIDS defined by clinical episodes]. Med Clin (Barc) 1998 0.79
40 Analysis of quasispecies in the viral 5' untranslated region of hepatitis C virus to evaluate ribavirin mutagenic effect in patients receiving ribavirin and interferon-alfa. Eur J Clin Microbiol Infect Dis 2004 0.79
41 Structural normalization of the lymphoid tissue in asymptomatic HIV-infected patients after 48 weeks of potent antiretroviral therapy. AIDS 2001 0.78
42 Dynamics of serum cytokines in patients with visceral leishmaniasis and HIV-1 co-infection. Clin Exp Immunol 1998 0.78
43 Minimal liver injury in chronic hepatitis C virus infection is associated with low levels of soluble TNF-alpha/Fas receptors and acquisition in childhood. Liver 2001 0.78
44 Regression of invasive AIDS-related Kaposi's sarcoma following antiretroviral therapy. Clin Infect Dis 1998 0.77
45 Fluorescence resonance energy transfer analysis of CCR-V64I and SDF1-3'a polymorphisms: prevalence in southern Spain hiv type 1+ cohort and noninfected population. AIDS Res Hum Retroviruses 2001 0.77
46 [Prevalence of anti-LAV/HTLV-III in prostitutes in Seville]. Med Clin (Barc) 1986 0.77
47 Evidence for a role of T-helper type 2 cytokines in the acquisition of human immunodeficiency virus syncytium-inducing phenotype. Eur J Clin Invest 1998 0.76
48 Isolated anti-HBc and hepatitis B virus occult infection. Vox Sang 1991 0.76
49 Hepatitis E virus and HIV infection in homosexual men. Lancet 1995 0.76
50 [Hepatitis C]. Enferm Infecc Microbiol Clin 1991 0.75
51 HIV-1 progression in hepatitis-C-infected drug users. Lancet 2001 0.75
52 Does early zidovudine treatment prevent the emergency of syncytium-inducing human immunodeficiency virus? J Infect Dis 1994 0.75
53 Acquisition of syncytium-inducing HIV-1 strains during therapy with zidovudine alone or combined with alpha interferon or didanosine. Eur J Clin Microbiol Infect Dis 1996 0.75
54 HIV-1-Ag as the one marker in the early stage of HIV-1 infection. Vox Sang 1991 0.75
55 [Serological markers of infection caused by human immunodeficiency virus]. Med Clin (Barc) 1988 0.75
56 [The clinical impact of symptomatic visceral leishmaniasis on HIV-1 infection]. Med Clin (Barc) 1999 0.75
57 AIDS in haemophiliacs in Spain. Lancet 1985 0.75
58 [Should esophageal candidiasis be excluded from diagnostic criteria for acquired immunodeficiency syndrome?]. Med Clin (Barc) 1986 0.75
59 [Penetration of anti-LVA/HTLV-III in type A and B hemophiliacs. Clinical and immunologic follow-up]. Med Clin (Barc) 1986 0.75
60 [Prevention of the maternofilial transmission of the human immunodeficiency virus]. Med Clin (Barc) 1987 0.75
61 [Opportunistic infections and Kaposi's sarcoma in hemophiliacs. Analysis of a series of patients controlled in a hospital and evaluation of the medical behavior]. Rev Clin Esp 1987 0.75
62 [An evaluation of the efficacy of different commercial kits in the serological diagnosis of the early phase of human immunodeficiency virus infection]. Med Clin (Barc) 1990 0.75
63 [Antiretroviral treatment with nucleoside analogs does not decrease the viremia of the hepatitis C virus in patients with HIV-1 infection]. Med Clin (Barc) 1998 0.75
64 [Cost-benefit analysis of a program for vaccination against hepatitis B in health personnel of a hospital]. Med Clin (Barc) 1984 0.75
65 [Posttransfusion hepatitis]. Rev Clin Esp 1987 0.75
66 [Chronic hepatitis C in patients coinfected by human immunodeficiency virus]. Gastroenterol Hepatol 2002 0.75
67 [First case of acquired immune deficiency syndrome in a drug addict from Seville]. Med Clin (Barc) 1986 0.75
68 Hepatitis C virus infection in sexually promiscuous groups. Eur J Clin Microbiol Infect Dis 1990 0.75
69 [Serum and immunological markers of progression to acquired immunodeficiency syndrome in hemophiliacs]. Med Clin (Barc) 1989 0.75
70 Cytokine network and HIV syncytium-inducing phenotype shift. AIDS 1996 0.75
71 Antibodies to human T-cell leukemia virus type III in hemophiliacs from Spain. Blood 1985 0.75
72 Predictive value of the presence of P24 antigen in persons with antibodies to human immunodeficiency virus in Spain. Eur J Clin Microbiol Infect Dis 1989 0.75
73 Failure to detect silent HIV infection by polymerase chain reaction in subjects at risk for heterosexually transmitted HIV type 1 infection. Eur J Clin Microbiol Infect Dis 1993 0.75
74 [Epidemiology of viral B hepatitis in hospital medical staff. A source considered 2 years later]. Med Clin (Barc) 1986 0.75
75 Recombinant EIA for anti-HIV testing is more specific than conventional EIA. Vox Sang 1988 0.75
76 A pilot case-control study of zidovudine compared with zidovudine plus didanosine in patients with advanced HIV-1 disease and no previous experience with antiretrovirals. Antivir Ther 1996 0.75
77 Immunological and virological effects of highly active antiretroviral therapy in two HIV-1 infected children. Acta Paediatr 2000 0.75
78 [Impact of delayed discharge for nonmedical reasons in a tertiary hospital internal medicine department]. Rev Clin Esp 2012 0.75
79 [Impact of acquired immunodeficiency syndrome on sex habits of a cohort of homosexuals]. Med Clin (Barc) 1988 0.75
80 [Acquired immune deficiency syndrome in Spain. Is the alarm justified?]. Med Clin (Barc) 1985 0.75
81 [Granulomatous pneumonitis: a clinical manifestation and atypical pathology of pneumocystosis in AIDS]. Med Clin (Barc) 1995 0.75
82 [Post-transfusion hepatitis. A pending issue]. Med Clin (Barc) 1988 0.75
83 [Serum expression of human immunodeficiency virus antigen(s) in persons at risk. Evidence of disappearance of HIV-Ag during the developmental course of patients with acquired immunodeficiency syndrome]. Med Clin (Barc) 1987 0.75
84 High rate of nonspecific anti-hepatitis C reactivity amongst homosexual men in comparison with that found in other sexually active groups and blood donors. Viral Hepatitis and AIDS Study Group. J Intern Med 1994 0.75
85 [Vaccination against viral hepatitis type B in Spain. Commentaries on a royal decree]. Med Clin (Barc) 1984 0.75
86 [Acquired cellular immunodeficiency syndrome: 3 observations in hemophiliacs]. Med Clin (Barc) 1983 0.75
87 [Lymphocyte subpopulations in hemophilia A and B]. Med Clin (Barc) 1984 0.75
88 [The Internal Medicine Department in the Social Security Health Centers]. Med Clin (Barc) 1983 0.75
89 [AIDS: the population at risk?]. Med Clin (Barc) 1988 0.75
90 [Effect of treatment with nucleoside analogues in subjects with primary genotypic resistance to zidovudine]. Med Clin (Barc) 1996 0.75
91 Viraemia and p24 antigenaemia are independent risk factors for the emergency of a zidovudine-resistant genotype in nucleoside analogue-treated HIV-1 infection. Antivir Ther 1997 0.75
92 Short-term evolution of HIV-1 viraemia and CD4+ cell counts in patients who have a primary mutation to zidovudine. AIDS 1998 0.75
93 [Epidemiology of viral hepatitis in the health personnel of a general hospital. A 10-year prospective study]. Med Clin (Barc) 1986 0.75
94 [Self-limited steatorrhea and chronic autoimmune hepatitis type I. The Group for the Study of Viral Hepatitis and AIDS]. Gastroenterol Hepatol 1995 0.75
95 [Significance of lymph node histology in patients with human immunodeficiency virus infection]. Rev Clin Esp 1988 0.75
96 [Prevalence of human immunodeficiency virus antibodies in inmates and officials of penitentiaries]. Rev Clin Esp 1987 0.75
97 [Liver cirrhosis and the renin-angiotensin-aldosterone system]. Rev Esp Enferm Apar Dig 1986 0.75
98 [Comparison of radioimmunoassay with enzyme immunoassay in the detection of serum antibodies against the human immunodeficiency virus]. Med Clin (Barc) 1987 0.75
99 [Viral hepatitis in hemophiliac patients treated with commercial concentrates of factors VIII and IX]. Med Clin (Barc) 1985 0.75
100 [Myxoma of the right atrium. Unusual hemodynamic data and ultrastructural study]. Med Clin (Barc) 1983 0.75
101 [Infection by hepatitis B virus in prostitutes: a public health problem]. Med Clin (Barc) 1986 0.75
102 [Prevalence of serum markers of hepatitis B virus in medical and non-medical personnel in a general hospital]. Med Clin (Barc) 1984 0.75
103 [Hepatitis caused by carbamazepine]. Med Clin (Barc) 1984 0.75
104 Low levels of HIV-1 plasma viral load in patients infected with HIV-1 subtype b and advanced immunosuppression. J Infect 2001 0.75
105 [Acquired immunodeficiency syndrome (AIDS) in hemophiliacs. Clinical course and post-mortem examination of the first cases described in Spain]. Med Clin (Barc) 1984 0.75
106 Can the determination of HIV-1 Ag in serum be useful in identifying hemophiliac patients who end up developing AIDS? Vox Sang 1989 0.75
107 [Ganglioneuroblastoma in the adult]. Med Clin (Barc) 1983 0.75
108 Rotative agitation RIA. A high sensitivity technique for hepatitis B surface antigen (HBsAg) determinations. J Hepatol 1986 0.75
109 [Viral hepatitis]. Med Clin (Barc) 1984 0.75
110 [Gypsies and other groups at risk for hepatitis B virus]. Med Clin (Barc) 1987 0.75
111 [Intrafamilial horizontal transmission of the human immunodeficiency virus in an area of low incidence]. Med Clin (Barc) 1988 0.75
112 [Prevalence of serum markers of hepatitis A and B viruses in Andalusian homosexual men]. Med Clin (Barc) 1985 0.75
113 HIV-1 viraemia changes in patients with and without syncytium-inducing phenotype treated with nucleoside analogues: a case-control study. Eur J Clin Invest 1996 0.75
114 Antibodies to the AIDS-associated retrovirus in hemophiliacs and other individuals from southern Spain: lack of correlation with lymphocytes sub-populations. AIDS Res 1986 0.75
115 [Hepatitis B in hospital personnel]. Med Clin (Barc) 1987 0.75
116 [Hepatitis B and C virus mutants. Clinical and therapeutical implications]. Gastroenterol Hepatol 1995 0.75